CNCE Message Board Post 10895916 | Concert Pharmaceuticals...
home / stock / cnce / cnce message board
(investorshangout)
Posted on: Jun/07/2022 16:00:56
Source: investorshangout
https://investorshangout.com/post/view?id=6416812
whytestocks: $CNCE News Article - Phase 2 Dose?Ranging Clinical Trial Results of CTP?543 in Patients with Alopeci
News, Short Squeeze, Breakout and More Instantly...
Concert Pharmaceuticals Inc. Company Name:
CNCE Stock Symbol:
Market:
Concert Pharmaceuticals Inc. Website:
-
Concert Pharmaceuticals, Inc. today announced that, after a recent review of deuruxolitinib clinical data by the U.S. Food and Drug Administration (FDA), the FDA determined that deuruxolitinib will maintain its Breakthrough Therapy designation. Deuruxolitinib, an oral Janus kinase (JAK) inhibit...
-
NEW YORK, NY / ACCESSWIRE / January 24, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Concert Pharmaceuticals, Inc. (NASDAQ...
-
If all goes according to plan, Concert Pharmaceuticals (NASDAQ: CNCE) will soon cease to be an independent company. The biotech signed a deal to be acquired by a peer; as a result, its share price leaped more than 17% higher on the week, according to data compiled by S&P Global Mark...